These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 24474455)
1. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women. González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455 [TBL] [Abstract][Full Text] [Related]
2. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women. Silva NNT; Sabino AP; Tafuri A; Lima AA BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928 [TBL] [Abstract][Full Text] [Related]
3. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Agodi A; Barchitta M; Cipresso R; Marzagalli R; La Rosa N; Caruso M; Castiglione MG; Travali S Int J Gynecol Cancer; 2010 Jan; 20(1):141-6. PubMed ID: 20130515 [TBL] [Abstract][Full Text] [Related]
4. The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Sull JW; Jee SH; Yi S; Lee JE; Park JS; Kim S; Ohrr H Gynecol Oncol; 2004 Dec; 95(3):557-63. PubMed ID: 15581963 [TBL] [Abstract][Full Text] [Related]
5. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis. Zhu J; Wu L; Kohlmeier M; Ye F; Cai W Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153 [TBL] [Abstract][Full Text] [Related]
6. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis. Wu CY; Yang M; Lin M; Li LP; Wen XZ Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325 [TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Piyathilake CJ; Macaluso M; Johanning GL; Whiteside M; Heimburger DC; Giuliano A Anticancer Res; 2000; 20(3A):1751-7. PubMed ID: 10928104 [TBL] [Abstract][Full Text] [Related]
8. Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12. Tong SY; Kim MK; Lee JK; Lee JM; Choi SW; Friso S; Song ES; Lee KB; Lee JP Cancer Causes Control; 2011 Jan; 22(1):63-72. PubMed ID: 21052817 [TBL] [Abstract][Full Text] [Related]
9. The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women. Tong SY; Lee JM; Song ES; Lee KB; Kim MK; Yun YM; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI Cancer Causes Control; 2010 Jan; 21(1):23-30. PubMed ID: 19760026 [TBL] [Abstract][Full Text] [Related]
10. The effect of methylenetetrahydrofolate reductase polymorphisms on susceptibility to human papilloma virus infection and cervical cancer. Hajiesmaeil M; Tafvizi F; Sarmadi S Infect Genet Evol; 2016 Dec; 46():1-6. PubMed ID: 27771518 [TBL] [Abstract][Full Text] [Related]
11. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618 [TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis. Long S; Yang X; Liu X; Yang P PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018 [TBL] [Abstract][Full Text] [Related]
13. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis. Yi K; Yang L; Lan Z; Xi M Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954 [TBL] [Abstract][Full Text] [Related]
14. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829 [TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Agorastos T; Lambropoulos AF; Constantinidis TC; Kotsis A; Bontis JN Eur J Cancer Prev; 2000 Apr; 9(2):113-8. PubMed ID: 10830578 [TBL] [Abstract][Full Text] [Related]
16. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk. Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536 [TBL] [Abstract][Full Text] [Related]
17. The association between MTHFR polymorphism and cervical cancer. Gong JM; Shen Y; Shan WW; He YX Sci Rep; 2018 May; 8(1):7244. PubMed ID: 29740106 [TBL] [Abstract][Full Text] [Related]
18. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419 [TBL] [Abstract][Full Text] [Related]
20. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India. Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]